Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
Main Author: | Fabiola Beligotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00151/full |
Similar Items
-
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
by: Klaus F. Bühler, et al.
Published: (2021-06-01) -
Comparative pharmacology of a new recombinant FSH expressed by a human cell line
by: Wolfgang Koechling, et al.
Published: (2017-07-01) -
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
by: Human Fatemi, et al.
Published: (2021-05-01) -
An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data
by: D. P. Kamilova, et al.
Published: (2021-03-01) -
Influence of human chorionic gonadotrophin during ovarian stimulation: an overview
by: Johan Smitz, et al.
Published: (2020-08-01)